{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:24:10Z","timestamp":1783538650988,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vancomycin is a naturally occurring cell-wall-targeting glycopeptide antibiotic. Due to the low potency of this antibiotic against Gram-negative pathogens, such as <jats:italic>Escherichia coli<\/jats:italic>, there is a limited knowledge about interactions between vancomycin and this group of bacteria. Here, we show that an in-frame 63\u2009bp deletion of the <jats:italic>lpp<\/jats:italic> gene caused a fourfold increase in vancomycin resistance in <jats:italic>E. coli<\/jats:italic>. The resulting protein, Lpp\u039421, is 21 amino acids shorter than the wild-type Lpp, a helical structural lipoprotein that controls the width of the periplasmic space through its length. The mutant remains susceptible to synergistic growth inhibition by combination of furazolidone and vancomycin; with furazolidone decreasing the vancomycin MIC by eightfold. These findings have clinical relevance, given that the vancomycin concentration required to select the <jats:italic>lpp<\/jats:italic> mutation is reachable during typical vancomycin oral administration for treating <jats:italic>Clostridioides difficile<\/jats:italic> infections. Combination therapy with furazolidone, however, is likely to prevent emergence and outgrowth of the <jats:italic>lpp<\/jats:italic>-mutated Gram-negative coliforms, avoiding exacerbation of the patient\u2019s condition during the treatment.<\/jats:p>","DOI":"10.1038\/s41429-023-00658-3","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T10:02:23Z","timestamp":1695636143000},"page":"746-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["When less is more: shortening the Lpp protein leads to increased vancomycin resistance in Escherichia coli"],"prefix":"10.1038","volume":"76","author":[{"given":"Hannah","family":"Wykes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9576-5246","authenticated-orcid":false,"given":"Vuong Van Hung","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrina","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-4682","authenticated-orcid":false,"given":"Jasna","family":"Rakonjac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"658_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1021\/cr030103a","volume":"105","author":"D Kahne","year":"2005","unstructured":"Kahne D, Leimkuhler C, Lu W, Walsh C. Glycopeptide and lipoglycopeptide antibiotics. Chem Rev. 2005;105:425\u201348.","journal-title":"Chem Rev"},{"key":"658_CR2","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/AAC.03147-14","volume":"60","author":"R \u00c1lvarez","year":"2016","unstructured":"\u00c1lvarez R, Cort\u00e9s LEL, Molina J, Cisneros JM, Pach\u00f3n J. Optimizing the clinical use of vancomycin. Antimicrob Agents Chemother. 2016;60:2601\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"658_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-363","volume":"10","author":"M Gonzales","year":"2010","unstructured":"Gonzales M, Pepin J, Frost EH, Carrier JC, Sirard S, Fortier L-C, et al. Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection. BMC Infect Dis. 2010;10:363.","journal-title":"BMC Infect Dis"},{"key":"658_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","volume":"1794","author":"AH Delcour","year":"2009","unstructured":"Delcour AH. Outer membrane permeability and antibiotic resistance. Biochim et Biophys Acta (BBA) - Proteins Proteom. 2009;1794:808\u201316.","journal-title":"Biochim et Biophys Acta (BBA) - Proteins Proteom"},{"key":"658_CR5","doi-asserted-by":"publisher","first-page":"001304","DOI":"10.1099\/jmm.0.001304","volume":"70","author":"C Olivera","year":"2021","unstructured":"Olivera C, Le VVH, Davenport C, Rakonjac J. In vitro synergy of 5-nitrofurans, vancomycin and sodium deoxycholate against Gram-negative pathogens. J Med Microbiol. 2021;70:001304.","journal-title":"J Med Microbiol"},{"key":"658_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1021\/acsinfecdis.5b00114","volume":"2","author":"V Yarlagadda","year":"2016","unstructured":"Yarlagadda V, Manjunath GB, Sarkar P, Akkapeddi P, Paramanandham K, Shome BR, et al. Glycopeptide antibiotic to overcome the intrinsic resistance of Gram-negative bacteria. ACS Infect Dis. 2016;2:132\u20139.","journal-title":"ACS Infect Dis"},{"key":"658_CR7","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1021\/acsinfecdis.1c00318","volume":"7","author":"E van Groesen","year":"2021","unstructured":"van Groesen E, Slingerland CJ, Innocenti P, Mihajlovic M, Masereeuw R, Martin NI. Vancomyxins: Vancomycin-polymyxin nonapeptide conjugates that retain anti-Gram-positive activity with enhanced potency against Gram-negative strains. ACS Infect Dis. 2021;7:2746\u201354.","journal-title":"ACS Infect Dis"},{"key":"658_CR8","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1021\/acschembio.9b00565","volume":"14","author":"A Antonoplis","year":"2019","unstructured":"Antonoplis A, Zang X, Wegner T, Wender PA, Cegelski L. Vancomycin\u2013arginine conjugate inhibits growth of carbapenem-resistant E. coli and targets cell-wall synthesis. ACS Chem Biol. 2019;14:2065\u201370.","journal-title":"ACS Chem Biol"},{"key":"658_CR9","doi-asserted-by":"publisher","first-page":"2006.0008","DOI":"10.1038\/msb4100050","volume":"2","author":"T Baba","year":"2006","unstructured":"Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, et al. Construction of Escherichia coli K\u201012 in\u2010frame, single\u2010gene knockout mutants: the Keio collection. Mol Syst Biol. 2006;2:2006.0008.","journal-title":"Mol Syst Biol"},{"key":"658_CR10","unstructured":"Cockerill FR, Wikler MA, Alder J, Dudley MN, Eliopoulos GM, Ferraro MJ, et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard\u2014Ninth Edition. Clinical and Laboratory Standards Institute; 2012"},{"key":"658_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1.","journal-title":"J Antimicrob Chemother"},{"key":"658_CR12","doi-asserted-by":"publisher","first-page":"e00868","DOI":"10.1128\/AAC.00868-19","volume":"63","author":"VVH Le","year":"2019","unstructured":"Le VVH, Davies IG, Moon CD, Wheeler D, Biggs PJ, Rakonjac J. Novel 5-nitrofuran-activating reductase in Escherichia coli. Antimicrob Agents Chemother. 2019;63:e00868\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"658_CR13","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul SF, Madden TL, Sch\u00e4ffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389\u2013402.","journal-title":"Nucleic Acids Res"},{"key":"658_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1006\/jmbi.2000.3776","volume":"299","author":"W Shu","year":"2000","unstructured":"Shu W, Liu J, Ji H, Lu M. Core structure of the outer membrane lipoprotein from Escherichia coli at 1.9 \u00e5 resolution. J Mol Biol. 2000;299:1101\u201312.","journal-title":"J Mol Biol"},{"key":"658_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita M, Sch\u00fctze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods. 2022;19:679\u201382.","journal-title":"Nat Methods"},{"key":"658_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70\u201382.","journal-title":"Protein Sci"},{"key":"658_CR17","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1365-2958.2011.07539.x","volume":"79","author":"CE Cowles","year":"2011","unstructured":"Cowles CE, Li Y, Semmelhack MF, Cristea IM, Silhavy TJ. The free and bound forms of Lpp occupy distinct subcellular locations in Escherichia coli. Mol Microbiol. 2011;79:1168\u201381.","journal-title":"Mol Microbiol"},{"key":"658_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15489-1","volume":"11","author":"M Matheli\u00e9-Guinlet","year":"2020","unstructured":"Matheli\u00e9-Guinlet M, Asmar AT, Collet J-F, Dufr\u00eane YF. Lipoprotein Lpp regulates the mechanical properties of the E. coli cell envelope. Nat Commun. 2020;11:1\u201311.","journal-title":"Nat Commun"},{"key":"658_CR19","doi-asserted-by":"publisher","first-page":"e2004303","DOI":"10.1371\/journal.pbio.2004303","volume":"15","author":"AT Asmar","year":"2017","unstructured":"Asmar AT, Ferreira JL, Cohen EJ, Cho S-H, Beeby M, Hughes KT, et al. Communication across the bacterial cell envelope depends on the size of the periplasm. PLoS Biol. 2017;15:e2004303.","journal-title":"PLoS Biol"},{"key":"658_CR20","doi-asserted-by":"publisher","first-page":"e73516","DOI":"10.7554\/eLife.73516","volume":"11","author":"E Mandela","year":"2022","unstructured":"Mandela E, Stubenrauch CJ, Ryoo D, Hwang H, Cohen EJ, Torres VL, et al. Adaptation of the periplasm to maintain spatial constraints essential for cell envelope processes and cell viability. eLife 2022;11:e73516.","journal-title":"eLife"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-023-00658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-023-00658-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-023-00658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:03:02Z","timestamp":1701043382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-023-00658-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1038\/s41429-023-00658-3","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"15 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}